2,000 Shares in SPDR S&P Biotech ETF (NYSEARCA:XBI) Purchased by Viewpoint Capital Management LLC

Viewpoint Capital Management LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 2,000 shares of the exchange traded fund’s stock, valued at approximately $180,000.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of SPDR S&P Biotech ETF by 198.6% during the 3rd quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 9,229,000 shares of the exchange traded fund’s stock worth $911,825,000 after buying an additional 6,138,000 shares during the period. Clal Insurance Enterprises Holdings Ltd acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $141,284,000. Assetmark Inc. grew its position in shares of SPDR S&P Biotech ETF by 72,653.0% during the 3rd quarter. Assetmark Inc. now owns 589,299 shares of the exchange traded fund’s stock worth $58,223,000 after buying an additional 588,489 shares during the period. Sivik Global Healthcare LLC acquired a new position in shares of SPDR S&P Biotech ETF during the 3rd quarter worth about $29,640,000. Finally, Mirae Asset Securities USA Inc. grew its position in shares of SPDR S&P Biotech ETF by 50.0% during the 3rd quarter. Mirae Asset Securities USA Inc. now owns 900,000 shares of the exchange traded fund’s stock worth $88,920,000 after buying an additional 300,000 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.4 %

SPDR S&P Biotech ETF stock opened at $89.05 on Wednesday. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47. The firm has a market capitalization of $6.79 billion, a P/E ratio of 11.47 and a beta of 1.11. The business has a 50-day moving average of $92.23 and a 200-day moving average of $96.30.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.